Literature DB >> 25969586

End-stage hypertrophic cardiomyopathy in a cat.

Andrew J M White1.   

Abstract

A 14-year-old Persian cat was referred for evaluation of the progression of hypertrophic cardiomyopathy (HCM) after an acute episode of congestive heart failure. The diagnosis of HCM had been made almost 13 years ago. Echocardiography and electrocardiography revealed end-stage hypertrophic cardiomyopathy and multifocal atrial tachycardia. The patient was discharged on medical management with a grave prognosis.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25969586      PMCID： PMC4399740     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  8 in total

1.  Natural history of hypertrophic cardiomyopathy and aortic thromboembolism in a family of domestic shorthair cats.

Authors:  C J Baty; D E Malarkey; C E Atkins; T C DeFrancesco; J Sidley; B W Keene
Journal:  J Vet Intern Med       Date:  2001 Nov-Dec       Impact factor: 3.333

2.  Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.

Authors:  P R Fox; J E Rush; C A Reynolds; T C Defrancesco; B W Keene; C E Atkins; S G Gordon; K E Schober; J D Bonagura; R L Stepien; H B Kellihan; K A Macdonald; L B Lehmkuhl; T P Nguyenba; N Sydney Moise; B K Lefbom; D F Hogan; M A Oyama
Journal:  J Vet Intern Med       Date:  2011-08-30       Impact factor: 3.333

3.  Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy.

Authors:  M F Cesta; C J Baty; B W Keene; I W Smoak; D E Malarkey
Journal:  Vet Pathol       Date:  2005-07       Impact factor: 2.221

4.  Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease.

Authors:  M D Kittleson; K M Meurs; M J Munro; J A Kittleson; S K Liu; P D Pion; J A Towbin
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

5.  Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.

Authors:  Gerhard Wess; Patricia Daisenberger; Monia Mahling; Johannes Hirschberger; Katrin Hartmann
Journal:  Vet Clin Pathol       Date:  2011-03-24       Impact factor: 1.180

6.  Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999).

Authors:  John E Rush; Lisa M Freeman; Nathaniel K Fenollosa; Donald J Brown
Journal:  J Am Vet Med Assoc       Date:  2002-01-15       Impact factor: 1.936

7.  Prevalence of cardiomyopathy in apparently healthy cats.

Authors:  Christopher F Paige; Jonathan A Abbott; François Elvinger; R Lee Pyle
Journal:  J Am Vet Med Assoc       Date:  2009-06-01       Impact factor: 1.936

8.  Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989).

Authors:  C E Atkins; A M Gallo; I D Kurzman; P Cowen
Journal:  J Am Vet Med Assoc       Date:  1992-08-15       Impact factor: 1.936
  8 in total
  2 in total

1.  Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.

Authors:  Keisuke Sugimoto; Takuma Aoki; Yoko Fujii
Journal:  J Vet Med Sci       Date:  2020-03-19       Impact factor: 1.267

2.  The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.

Authors:  Mark D Kittleson; Etienne Côté
Journal:  J Feline Med Surg       Date:  2021-11       Impact factor: 2.015
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.